AMY STEINHOFF: Open Payments
NPI 1164763421 · SUN CITY WEST, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,459 in 68 payments from 20 companies in 2025. Trend: 2023 $1,777 · 2024 $2,137 · 2025 $1,459
Food & beverage: $1,459
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $213 |
| Astellas Pharma US Inc | 7 | $190 |
| Amgen Inc. | 12 | $167 |
| AstraZeneca Pharmaceuticals LP | 5 | $166 |
| Edwards Lifesciences Corporation | 2 | $162 |
| PFIZER INC. | 5 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $90 |
| Novo Nordisk Inc | 4 | $78 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Radius Health, Inc. | 2 | $42 |
Products named: Veozah, SAPIEN 3 Ultra RESILIA, BREZTRI, XIFAXAN, VRAYLAR, EVENITY, UBRELVY, GEMTESA.
Industry payments across AZ — which companies pay providers there.
